Increase (Decrease) in Stockholders' Equity Increase (Decrease) in Stockholders' Equity [Roll Forward] Total future minimum lease payments Lessee, Operating Lease, Liability, to be Paid Schedule of Cash and Cash Equivalents Schedule of Cash and Cash Equivalents [Table Text Block] Related Party Transactions [Abstract] Related Party Transactions [Abstract] Spark Letter Agreement Spark Letter Agreement [Member] Spark Letter Agreement [Member] Class of warrant or right, number of warrants exercised (in shares) Class Of Warrant Or Right, Number Of Warrants Exercised Class of Warrant or Right, Number Of Warrants Exercised Fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, transfers, net Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net Entity Address, Postal Zip Code Entity Address, Postal Zip Code Weighted-average remaining contractual term Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term [Abstract] n/a Area of additional office space leased Area of Real Estate Property Additions Contract with Customer, Liability, Increase From Cash Receipts Contract with Customer, Liability, Increase From Cash Receipts Property, Plant and Equipment [Abstract] Property, Plant and Equipment [Abstract] Preferred stock, shares outstanding (in shares) Preferred Stock, Shares Outstanding 2024 Long-Term Debt, Maturity, Year Two Total property and equipment Property, Plant and Equipment, Gross Consulting services expenses Related Party Transaction, Expenses from Transactions with Related Party Maximum borrowing capacity Line of Credit Facility, Maximum Borrowing Capacity Income Tax Disclosure [Abstract] Income Tax Disclosure [Abstract] Depreciation Deferred Tax Liabilities, Property, Plant and Equipment Fair Value of Financial Instruments Fair Value of Financial Instruments, Policy [Policy Text Block] Additional paid-in capital Additional Paid in Capital Number of amendments License and Option Agreement, Number Of Amendments License and Option Agreement, Number Of Amendments Cash flows from investing activities Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract] Financial Instruments [Domain] Financial Instruments [Domain] Depreciation and amortization Other Depreciation and Amortization Basis spread on variable rate Debt Instrument, Basis Spread on Variable Rate Issuance (in dollars per share) Stock Issued During, Warranted Issued, Price Per Share Stock Issued During, Warranted Issued, Price Per Share Statistical Measurement [Domain] Statistical Measurement [Domain] Accrued external research and development costs Accrued Research And Development Costs Current Carrying value as of the balance sheet date of research and development costs. Depreciation expense Depreciation Issuance of common stock upon exercise of options (in shares) Exercised (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Net deferred tax assets Deferred Tax Assets, Net AskBio License Agreement AskBio License Agreement [Member] AskBio License Agreement Operating lease, weighted average discount rate, percent Operating Lease, Weighted Average Discount Rate, Percent Valuation Approach and Technique [Axis] Valuation Approach and Technique [Axis] Number of votes per share that common stockholders are entitled to Votes Per Share of Common Stock Votes Per Share of Common Stock Share-based Payment Arrangement [Abstract] Share-Based Payment Arrangement [Abstract] Other Current Assets Other Current Assets [Member] Debt Instrument, Redemption, Period Three Debt Instrument, Redemption, Period Three [Member] Domestic Tax Authority Domestic Tax Authority [Member] Net income (loss) Net income (loss) Net Income (Loss) Attributable to Parent August 2020 Shelf Registration Statement August 2020 Shelf Registration Statement [Member] August 2020 Shelf Registration Statement Measurement Input Type [Domain] Measurement Input Type [Domain] Lessee, Lease, Description [Table] Lessee, Lease, Description [Table] Potential common shares Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Total (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Schedule of Future Minimum Payments on the Term Loans Schedule of Maturities of Long-Term Debt [Table Text Block] Subsequent Event Type [Axis] Subsequent Event Type [Axis] Other Effective Income Tax Rate Reconciliation, Other Adjustments, Percent Thereafter Lessee, Operating Lease, Liability, to be Paid, after Year Five Warrants Warrants [Policy Text Block] Warrants Equity Component [Domain] Equity Component [Domain] Subsequent Event Type [Domain] Subsequent Event Type [Domain] Audit Information [Abstract] Audit Information [Abstract] Ownership [Axis] Ownership [Axis] Total assets Assets, Fair Value Disclosure Class of Warrant or Right [Line Items] Class of Warrant or Right [Line Items] Leases Lessee, Operating Leases [Text Block] Valuation Approach and Technique [Domain] Valuation Approach and Technique [Domain] Issuance costs paid for December 2019 financing Payments of Financing Costs Non-cash lease expense Finance Lease, Right-of-Use Asset, Amortization Related Party [Domain] Related Party [Domain] Billed Revenues Billed Revenues [Member] Lessee, Lease, Description [Line Items] Lessee, Lease, Description [Line Items] Equity securities without readily determinable fair value, impairment loss Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount Plan Name [Axis] Plan Name [Axis] Employment Inducement Incentive Award Plan Employment Inducement Incentive Award Plan [Member] Employment Inducement Incentive Award Plan [Member] Fair value Marketable securities: Debt Securities, Available-for-Sale Dividend yield Measurement Input, Expected Dividend Rate [Member] Vesting period Defined Contribution Plan Employers Matching Contribution Vesting Period Period which an employee's right to exercise a plan is no longer contingent on satisfaction of either a service condition, market condition or a performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Supplement cash flow information Supplemental Cash Flow Information [Abstract] Forfeited (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Number of operating segments Number of Operating Segments Unrecognized compensation expense Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount Plan Name [Domain] Plan Name [Domain] State net operating loss carryforwards Deferred Tax Assets, Operating Loss Carryforwards, State and Local Clinical Trial Costs Clinical Trial Costs [Policy Text Block] Clinical Trial Costs Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Term loan facility Long-Term Line of Credit Entity Address, State or Province Entity Address, State or Province Level 1 Fair Value, Inputs, Level 1 [Member] Lease Arrangement [Axis] Lease Arrangement [Axis] Lease Arrangement [Axis] Outstanding, term Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Unbilled receivable Increase (Decrease) In Contract with Customer, Asset, Allowance for Credit Loss, Current Increase (Decrease) In Contract with Customer, Asset, Allowance for Credit Loss, Current Skolkovo Skolkovo [Member] Skolkovo Accrued interest Accrued Interest, Current Accrued Interest, Current Award Type [Axis] Award Type [Axis] Net cash (used in) provided by operating activities Net Cash Provided by (Used in) Operating Activities 65 Grove Street, Watertown,MA 65 Grove Street, Watertown,MA [Member] 65 Grove Street, Watertown,MA [Member] Lease liability Operating Lease, Liability, Current Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table] Summary of Available-for-Sale Marketable Securities Debt Securities, Available-for-Sale [Table Text Block] Permanent items Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent TAS Partners, LLC (affiliate of Timothy A. Springer, Ph.D.) TAS Partners, LLC [Member] TAS Partners, LLC [Member] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Reclassification of warrant liability to equity on modification (in dollars per share) Stock Issued During, Warrant Reclassification to Equity, Price Per Share Stock Issued During, Warrant Reclassification to Equity, Price Per Share Forfeited (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Document Annual Report Document Annual Report Liability Class [Axis] Liability Class [Axis] Schedule of Cash and Cash Equivalents [Table] Schedule of Cash and Cash Equivalents [Table] Total liabilities Liabilities Operating lease, weighted average remaining lease term Operating Lease, Weighted Average Remaining Lease Term Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Geographical [Axis] Geographical [Axis] Issuance of common stock, net of issuance costs Stock Issued During Period, Value, New Issues Accrued expenses and other liabilities Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities Operating Leased Assets [Line Items] Operating Leased Assets [Line Items] Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Reclassification of warrant liability to equity on modification (in shares) Stock Issued During Period Shares Warrant Reclassification to Equity Stock Issued During Period Shares Warrant Reclassification to Equity Schedule of Property and Equipment Property, Plant and Equipment [Table Text Block] Issuance of common stock upon exercise of pre-funded warrants Stock Issued During Period, Values, Pre-Funded Warrants Exercised Stock Issued During Period, Values, Pre-Funded Warrants Exercised Revenue Recognition Revenue from Contract with Customer [Policy Text Block] Marketable securities Debt Securities, Available-for-Sale, Current Preferred stock, shares issued (in shares) Preferred Stock, Shares Issued Document Type Document Type Weighted-average exercise price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Estimated useful life Property, Plant and Equipment, Useful Life Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Increase in letter of credit Line of Credit Facility, Increase (Decrease), Net Assets: Assets, Fair Value Disclosure [Abstract] Unvested at beginning of period (in dollars per share) Unvested at end of period (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Debt Debt Disclosure [Text Block] Operating expenses: Cost of Revenue [Abstract] Cash flows from operating activities Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract] Entity Shell Company Entity Shell Company December 2019 Financing December Two Thousand Nineteen Financing [Member] December Two Thousand Nineteen Financing [Member] Aggregate amount of upfront and milestone-based payments Aggregate Amount Of Upfront And Milestone Based Payments Paid Aggregate Amount Of Upfront And Milestone Based Payments Paid Concentration Risk [Table] Concentration Risk [Table] 2023 Lessee, Operating Lease, Liability, to be Paid, Year One Loan payable Loans Payable, Current Laboratory equipment Laboratory Equipment [Member] Represents information pertaining to laboratory equipment. Operating lease right-of-use assets Deferred Tax Liabilities, Operating Lease, Right-Of-Use Asset Deferred Tax Liabilities, Operating Lease, Right-Of-Use Asset Aggregate amount for future payments upon achievement of clinical and regulatory approval milestones for products containing ImmTOR platform Aggregate Amount For Future Payments Upon Achievement Of Clinical And Regulatory Approval Milestones For Products Containing ImmTOR Platform Aggregate Amount For Future Payments Upon Achievement Of Clinical And Regulatory Approval Milestones For Products Containing ImmTOR Platform Series B Preferred Stock Purchase Agreement Series B Preferred Stock Purchase Agreement [Member] Series B Preferred Stock Purchase Agreement Financial Instrument [Axis] Financial Instrument [Axis] Proceeds from exercise of pre-funded and common warrants Proceeds from Warrant Exercises 2025 Long-Term Debt, Maturity, Year Three Affiliated Entity Affiliated Entity [Member] Other comprehensive income (loss): Other Comprehensive Income (Loss), Tax [Abstract] Subsequent Event Subsequent Event [Member] Schedule of Changes in Contract Liabilities Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block] Document Period End Date Document Period End Date Pre-Funded Warrant Pre-Funded Warrant [Member] Pre-Funded Warrant [Member] Issuance of common stock, license agreement (in shares) Stock Issued During the Period, Shares, Common Stock License Agreement Stock Issued During the Period, Shares, Common Stock License Agreement Income Tax Examination [Table] Income Tax Examination [Table] Equity securities, stock purchase agreement, par value per share (in dollars per share) Equity Securities, Stock Purchase Agreement, Par Value Per Share Equity Securities, Stock Purchase Agreement, Par Value Per Share Debt Securities, Available-for-sale [Table] Debt Securities, Available-for-Sale [Table] Total assets Assets Debt Disclosure [Abstract] Debt Disclosure [Abstract] Earnings Per Share [Abstract] Income Statement Location [Axis] Income Statement Location [Axis] Estimated penalties and interest Income Tax Examination, Penalties and Interest Expense Antidilutive Securities [Axis] Antidilutive Securities [Axis] Accrued expenses Accrued expenses Accrued Liabilities, Current Underwriting Agreement Underwriting Agreement [Member] Underwriting Agreement Less: Current portion of loan payable Long-Term Debt, Current Maturities Exercised (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 2027 Lessee, Operating Lease, Liability, to be Paid, Year Five Numerator: Net Income (Loss) Available to Common Stockholders, Basic [Abstract] Net cash provided by financing activities Net Cash Provided by (Used in) Financing Activities Accounting Policies [Abstract] Accounting Policies [Abstract] Number of obligations Revenue, Number Of Performance Obligations Revenue, Number Of Performance Obligations Interest expense related to term loans Interest Expense, Debt Issuance of common stock, license agreement in stock-based compensation expense Issuance of Common Stock, License Agreement in Stock-Based Compensation Expense Issuance of Common Stock, License Agreement in Stock-Based Compensation Expense Payroll and employee related expenses Employee-related Liabilities, Current Variable lease cost Variable Lease, Cost Income (loss) before income taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Stockholders’ equity: Stockholders' Equity Attributable to Parent [Abstract] Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Debt amendment fee included in debt discount Amortization of Debt Issuance Costs and Discounts Net Loss Per Share Earnings Per Share [Text Block] Disclosure of Share-based Compensation Arrangements by Share-based Payment Award Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award [Table Text Block] Schedule of Weighted Average Assumptions Used Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Related Party Transaction [Line Items] Related Party Transaction [Line Items] Award Type [Domain] Award Type [Domain] Valuation allowance, net Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent Class of warrant or right, number of securities called by warrants or rights (in shares) Class of Warrant or Right, Number of Securities Called by Warrants or Rights Weighted average period for recognition Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Loss on extinguishment of debt Loss on extinguishment of debt Gain (Loss) on Extinguishment of Debt MIT Exclusive Patent License Agreement With Massachusetts Institute Of Technology [Member] Represents information pertaining to Exclusive patent license agreement with Massachusetts Institute of Technology. " Proceeds from issuance of common stock under Employee Stock Purchase Plan Proceeds from Stock Plans Issuance of vested restricted stock units Stock Issued During Period, Value, Restricted Stock Award, Gross Computer equipment Computer equipment and software Computer Equipment [Member] Payment made for investments Payments to Acquire Other Investments Cash flows from financing activities Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract] Entity Registrant Name Entity Registrant Name Issuance of common stock, net of issuance costs (in shares) Stock Issued During Period, Shares, New Issues Other expenses Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Other Subsequent Events Subsequent Events [Text Block] Dividend yield Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate Non-employee stock options Non-employee consultants Non Employee Stock Option [Member] An arrangement whereby a non-employee is entitled to receive in the future, subject to vesting and other restrictions, a number of shares in the entity at a specified price, as defined in the agreement. Research and Development Arrangement, Contract to Perform for Others, Type [Axis] Research and Development Arrangement, Contract to Perform for Others, Type [Axis] Entity Address, City or Town Entity Address, City or Town Defined Contribution Plan Retirement Benefits [Text Block] Leases [Abstract] Leases [Abstract] Net deferred tax assets before valuation allowance Deferred Tax Assets, Net Of Deferred Tax Liabilities Deferred Tax Assets, Net Of Deferred Tax Liabilities Expected life (in years) Measurement Input, Expected Term [Member] Period after first commercial sale when the Company is eligible to receive royalties Eligible Period To Receive Royalties Eligible Period To Receive Royalties Net operating loss carryforwards Deferred Tax Assets, Operating Loss Carryforwards Principles of Consolidation Consolidation, Policy [Policy Text Block] ESPP Employee Stock Purchase Plan2016 [Member] Represent information pertaining to the 2016 Employee Stock Purchase Plan. Estimated forfeitures rate Share-based Compensation Arrangement By Share-based Payment Award Forfeitures Rate Represents the percentage of forfeitures rate of the stock options based on the historical trends. Minimum Minimum [Member] Short-term restricted cash Restricted Cash and Cash Equivalents, Current Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Entity Emerging Growth Company Entity Emerging Growth Company Capitalized Costs Capitalized Costs, Proved Properties Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Accrued interest related to uncertain tax positions Unrecognized Tax Benefits, Interest on Income Taxes Accrued Debt instrument, prepayment fee, percentage Debt Instrument, Prepayment Fee, Percentage Debt Instrument, Prepayment Fee, Percentage Income Tax Examination [Line Items] Income Tax Examination [Line Items] Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Auditor Name Auditor Name Fair Value Measurements Fair Value Disclosures [Text Block] Trading Symbol Trading Symbol Entity File Number Entity File Number 2016 Plan Stock Incentive Plan2016 [Member] Represents the information pertaining to the 2016 stock incentive plan, which provides for the granting of stock based awards to employees, directors, and consultants under terms and provisions established by the board of directors. Deferred revenue Long-term contract liability Contract with Customer, Liability, Noncurrent Research and development Research and Development Expense Laboratory equipment, software and office equipment Equipment [Member] Fair Value by Liability Class [Domain] Fair Value by Liability Class [Domain] Restricted cash and cash equivalents Restricted Cash and Cash Equivalents Grants in period (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Restricted Stock Units (RSUs) Restricted Stock Units (RSUs) [Member] Effective income tax rate Effective Income Tax Rate Reconciliation, Percent Vested, term Share-based Compensation Arrangement By Share-based Payment Award, Options, Vested, Outstanding, Weighted Average Remaining Contractual Term Share-based Compensation Arrangement By Share-based Payment Award, Options, Vested, Outstanding, Weighted Average Remaining Contractual Term Risk-free interest rate Measurement Input, Risk Free Interest Rate [Member] Vested and expected to vest (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Use of Estimates Use of Estimates, Policy [Policy Text Block] Money market funds (included in cash equivalents) Cash and Cash Equivalents, Fair Value Disclosure Final payment fee Debt Instrument, Periodic Payment Terms, Balloon Payment to be Paid Contract liabilities: Change In Contract With Customer, Liability [Roll Forward] Change In Contract With Customer, Liability [Roll Forward] Ginkgo Agreement Ginkgo Agreement [Member] Ginkgo Agreement Accounts payable Increase (Decrease) in Accounts Payable Fair value as of December 31, 2021 Fair value as of December 31, 2022 Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value Subsequent Events [Abstract] Subsequent Events [Abstract] Marketable Securities and Investments Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block] Investment income Investment Income, Net Income Taxes Income Tax Disclosure [Text Block] Moscow Russia Lease Moscow Russia Lease [Member] Moscow Russia Lease Issuance of common stock upon exercise of common warrants (in shares) Stock Issued During Period, Shares, Common Warrants Exercised Stock Issued During Period, Shares, Common Warrants Exercised Credit Facility [Domain] Credit Facility [Domain] Exercise price (in dollars per share) Exercise price, beginning balance (in dollars per share) Exercise price, ending balance (in dollars per share) Class of Warrant or Right, Exercise Price of Warrants or Rights Cash paid for interest Interest Paid, Excluding Capitalized Interest, Operating Activities Basic (in dollars per share) Earnings Per Share, Basic Term A Loans Term A Loans [Member] Term A Loans 2025 Lessee, Operating Lease, Liability, to be Paid, Year Three Schedule of Restricted Cash and Cash Equivalents Restrictions on Cash and Cash Equivalents [Table Text Block] Counterparty Name [Domain] Counterparty Name [Domain] Total stockholders’ equity Beginning balance Ending balance Stockholders' Equity Attributable to Parent Forfeited in period (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Dividends declared or paid on common stock Dividends, Common Stock Line of Credit Facility [Line Items] Line of Credit Facility [Line Items] Ownership [Domain] Ownership [Domain] Entity Interactive Data Current Entity Interactive Data Current Contract assets amortization (less than) Capitalized Contract Cost, Amortization Sale of stock, number of shares issued in transaction (in shares) Stock issued (in shares) Sale of Stock, Number of Shares Issued in Transaction Prepaid Expenses and Other Current Assets Prepaid Expenses and Other Current Assets [Member] Property, Plant and Equipment [Table] Property, Plant and Equipment [Table] Changes in operating assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] Schedule Of Changes In The Warrant Liabilities Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Money market funds (included in cash equivalents) Money Market Funds [Member] Accumulated deficit Retained Earnings [Member] Unrecognized compensation expense related to unvested employee stock options Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount Cash and Cash Equivalents [Line Items] Cash and Cash Equivalents [Line Items] Lessee-paid construction costs Total lease cost Lease, Cost Common stock Common Stock [Member] Common Stock [Member] Schedule of Lease, Cost Lease, Cost [Table Text Block] Number of shares authorized for grants (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant Class of Stock [Axis] Class of Stock [Axis] Income Taxes Income Tax, Policy [Policy Text Block] Statement [Table] Statement [Table] Vested in period (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Debt instrument, redemption price, percentage of principal amount redeemed Debt Instrument, Redemption Price, Percentage of Principal Amount Redeemed Operating lease, renewal term Lessee, Operating Lease, Renewal Term Letter of credit Letter of Credit [Member] Furniture and fixtures Furniture and Fixtures [Member] Current assets: Assets, Current [Abstract] Lease liability, net of current portion Operating Lease, Liability, Noncurrent Research and development credits Deferred Tax Assets, Tax Credit Carryforwards, Research Vested Share-based Compensation Arrangement By Share-based Payment Award, Options, Vested, Outstanding, Intrinsic Value Share-based Compensation Arrangement By Share-based Payment Award, Options, Vested, Outstanding, Intrinsic Value Schedule of Fair Value Measurement Inputs and Valuation Techniques Fair Value Measurement Inputs and Valuation Techniques [Table Text Block] Employer contribution made Defined Contribution Plan, Cost Statistical Measurement [Axis] Statistical Measurement [Axis] Leasehold improvements Leasehold Improvements [Member] Weighted-average fair value of common stock (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Fair Value Weighed-average fair value relating to the share-based payment award. Accumulated deficit Accumulated deficit Retained Earnings (Accumulated Deficit) Issuance of common stock and common warrants (in shares) Stock Issued During the Period, Shares, Common Stock and Warrants Stock Issued During the Period, Shares, Common Stock and Warrants Accounts receivable Accounts Receivable, after Allowance for Credit Loss, Current Equity Components [Axis] Equity Components [Axis] Recurring Fair Value, Recurring [Member] Net proceeds from issuance of common stock- private placement Proceeds from Issuance of Private Placement Milestone receivable for certain dystrophies License And Option Agreement, Milestone Receivable For Certain Dystrophies License And Option Agreement, Milestone Receivable For Certain Dystrophies Related-Party Transactions Related Party Transactions Disclosure [Text Block] Contractual payments defined in the Exclusive Patent License agreement License And Option Agreement, Contractual Payments Made License And Option Agreement, Contractual Payments Made Accumulated Other Comprehensive Income (Loss) Comprehensive Income, Policy [Policy Text Block] Segment Information Segment Reporting, Policy [Policy Text Block] Document Fiscal Year Focus Document Fiscal Year Focus Takeda Agreement Takeda Agreement [Member] Takeda Agreement Cash Equivalents, Restricted Cash, Marketable Securities and Investments Cash Equivalents And Short Term Investments [Policy Text Block] Cash Equivalents And Short Term Investments Statement [Line Items] Statement [Line Items] Warrants and rights outstanding, term Warrants and Rights Outstanding, Term Fair Value Measurement Inputs and Valuation Techniques [Table] Fair Value Measurement Inputs and Valuation Techniques [Table] R&E capitalization Deferred Tax Assets, in Process Research and Development Unvested at beginning of period (in shares) Unvested at end of period (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Redemption premium Redemption Premium Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Schedule of Operating Lease, Lease Income Operating Lease, Lease Income [Table Text Block] Current tax expense, inclusive of estimated penalties and interest Current Income Tax Expense (Benefit) Unrealized losses Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax Right-of-use asset, net Operating Lease, Right-of-Use Asset Accumulated other comprehensive loss AOCI Attributable to Parent [Member] Reclassification of warrant liability to equity upon modification Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers out of Level 3 Impairment of Long-Lived Assets Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block] Auditor Firm ID Auditor Firm ID Deferred Tax Liabilities Deferred Tax Liabilities, Gross [Abstract] Vested and expected to vest (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price Issuance of common stock, license agreement Stock Issued During the Period, Values, Common Stock License Agreement Stock Issued During the Period, Values, Common Stock License Agreement Document Transition Report Document Transition Report Local Phone Number Local Phone Number Extension term License And Option Agreement, Extension Term License And Option Agreement, Extension Term Equity securities, stock purchase agreement, purchase price per share (in dollars per share) Equity Securities, Stock Purchase Agreement, Purchase Price Per Share Equity Securities, Stock Purchase Agreement, Purchase Price Per Share Summary of Options Activity Share-Based Payment Arrangement, Option, Activity [Table Text Block] Operating income (loss) Operating Income (Loss) Federal operating loss carryforwards Deferred Tax Assets, Operating Loss Carryforwards, Domestic Recent Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] 2019 Warrants 2019 Warrants [Member] 2019 Warrants Stock-based compensation expense Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost Investments Equity securities without readily determinable fair value, amount Equity Securities without Readily Determinable Fair Value, Amount Prepaid expenses, deposits and other assets Increase (Decrease) in Prepaid Expense and Other Assets Development and Commercial Milestones Plus Royalties Development and Commercial Milestones Plus Royalties Development and Commercial Milestones Plus Royalties State and Local Jurisdiction State and Local Jurisdiction [Member] Common stock, shares outstanding (in shares) Beginning balance (in shares) Ending balance (in shares) Common Stock, Shares, Outstanding Total liabilities Liabilities, Fair Value Disclosure Long-Lived Tangible Asset [Axis] Long-Lived Tangible Asset [Axis] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Adjustments to reconcile net income (loss) to net cash used in operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Income tax (expense) benefit Income Tax Expense (Benefit) Geographical [Domain] Geographical [Domain] Valuation allowance Deferred Tax Assets, Valuation Allowance Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table] Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Table] Property and Equipment Property, Plant and Equipment, Policy [Policy Text Block] SOBI Purchase Agreement SOBI Purchase Agreement [Member] SOBI Purchase Agreement [Member] Preferred stock, par value (in dollars per share) Preferred Stock, Par or Stated Value Per Share Cost share percentage Collaborative Arrangement, Cost Share Percentage Collaborative Arrangement, Cost Share Percentage 2026 Lessee, Operating Lease, Liability, to be Paid, Year Four Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Springer Purchase Agreement Springer Purchase Agreement [Member] Springer Purchase Agreement [Member] Entity Public Float Entity Public Float Additional paid-in capital Additional Paid-in Capital [Member] Document Fiscal Period Focus Document Fiscal Period Focus Operating lease liabilities Deferred Tax Assets, Operating Lease, Liability Deferred Tax Assets, Operating Lease, Liability Long-term restricted cash Restricted Cash, Noncurrent Net loss per share: Earnings Per Share, Basic [Abstract] Venture debt termination fee Debt Instrument, Termination Fee Debt Instrument, Termination Fee Diluted (in shares) Weighted‑average common shares outstanding—diluted (in shares) Weighted Average Number of Shares Outstanding, Diluted 2017 Term Loans 2017 Term Loans [Member] 2017 Term Loans [Member] Less accumulated depreciation Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Expected term Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Collaborative Arrangement Collaborative Arrangement [Member] Debt Securities, Available-for-sale [Line Items] Debt Securities, Available-for-Sale [Line Items] ICFR Auditor Attestation Flag ICFR Auditor Attestation Flag Billing Status, Type [Axis] Billing Status, Type [Axis] First Acquisition Right First Acquisition Right [Member] First Acquisition Right [Member] Common stock, $0.0001 par value; 350,000,000 and 200,000,000 shares authorized as of December 31, 2022 and December 31, 2021, respectively; 153,042,435 and 123,622,965 shares issued and outstanding as of December 31, 2022 and December 31, 2021, respectively Common Stock, Value, Issued Future additional payments, expected License And Option Agreement, Future Additional Payments, Expected License And Option Agreement, Future Additional Payments, Expected Deferred Tax Assets Deferred Tax Assets, Gross [Abstract] Grants in period (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Cash, cash equivalents, restricted cash and marketable securities Cash, Cash Equivalents, Restricted Cash And Restricted Cash Equivalents And Debt Securities, Available-For-Sale Cash, Cash Equivalents, Restricted Cash And Restricted Cash Equivalents And Debt Securities, Available-For-Sale Issuance of vested restricted stock units (in shares) Stock Issued During Period, Shares, Restricted Stock Award, Gross Schedule of Potential Common Shares Issuable Upon Conversion of Warrants Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Underwriting Agreement - 2022 Warrants Underwriting Agreement - 2022 Warrants [Member] Underwriting Agreement - 2022 Warrants Summary of Assets Measured at Fair Value on a Recurring Basis Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Vested (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Exercise Price Equity securities, stock purchase agreement, shares purchased (in shares) Equity Securities, Stock Purchase Agreement, Shares Purchased Equity Securities, Stock Purchase Agreement, Shares Purchased Short-term lease cost Short-Term Lease, Cost Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Private Placement Private Placement [Member] Preferred stock, shares authorized (in shares) Preferred Stock, Shares Authorized Accrued professional and consulting services Accrued Audit Fees, Current Accrued Audit Fees, Current Class Of Warrant Or Right [Roll Forward] Class Of Warrant Or Right [Roll Forward] Class Of Warrant Or Right [Roll Forward] Cash, cash equivalents, and restricted cash at beginning of period Cash, cash equivalents, and restricted cash at end of period Total cash, cash equivalents, and restricted cash Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Class Of Warrant Or Right Weighted Average Exercise Price [Roll Forward] Class Of Warrant Or Right Weighted Average Exercise Price [Roll Forward] Class Of Warrant Or Right Weighted Average Exercise Price [Roll Forward] Foreign currency translation adjustment Currency translation adjustment Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Issuance of common warrants with long-term debt, net / Reclassification of warrant liabilities Grant date fair value of the warrants issued Adjustments to Additional Paid in Capital, Warrant Issued Warrants and rights outstanding, measurement input Warrants and Rights Outstanding, Measurement Input Current liabilities: Liabilities, Current [Abstract] Proceeds from exercise of stock options Proceeds from Stock Options Exercised Proceeds from issuance of long-term debt, net of expenses Proceeds from Issuance of Long-Term Debt Common stock, shares issued (in shares) Common Stock, Shares, Issued Vested and expected to vest, term Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term Concentration Risk [Line Items] Concentration Risk [Line Items] Issuance of common stock and common warrants Stock Issued During the Period, Values, Common Stock and Warrants Stock Issued During the Period, Values, Common Stock and Warrants Deferred revenue Short-term contract liability Contract with Customer, Liability, Current Purchase of property and equipment not yet paid Capital Expenditures Incurred but Not yet Paid Foreign currency transaction gain (loss), net Foreign Currency Transaction Gain (Loss), before Tax Warrant liabilities Warrant liabilities Warrants and Rights Outstanding Spark License Agreement License Agreement Terms [Member] Income Statement Location [Domain] Income Statement Location [Domain] Issuance of common stock upon exercise of warrants Stock Issued During Period, Value, Common Warrants Exercised Stock Issued During Period, Value, Common Warrants Exercised Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Amendment Flag Amendment Flag Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities Operating lease cost Operating Lease, Cost Face value Debt Instrument, Face Amount Issuance of common stock under Employee Stock Purchase Plan Stock Issued During Period, Value, Employee Stock Purchase Plan Total comprehensive income (loss) Comprehensive Income (Loss), Net of Tax, Attributable to Parent Construction in process Construction in Progress [Member] Unrealized gains Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax Entity Current Reporting Status Entity Current Reporting Status Goodwill and Intangible Assets Disclosure [Abstract] Goodwill and Intangible Assets Disclosure [Abstract] Long-term Debt, Fiscal Year Maturity [Abstract] Long-Term Debt, Fiscal Year Maturity [Abstract] Cashless warrant exercise Noncash Or Part Noncash, Warrant Exercises Noncash Or Part Noncash, Warrant Exercises License and option agreement, written day notice period before cancellation License And Option Agreement, Written Day Notice Period Before Cancellation License And Option Agreement, Written Day Notice Period Before Cancellation Development milestone License And Option Agreement, Development Milestone License And Option Agreement, Development Milestone Disaggregation of Revenue [Table] Disaggregation of Revenue [Table] Sarepta Therapeutics, Inc. Sarepta Therapeutics, Inc. [Member] Sarepta Therapeutics, Inc. [Member] Statutory U.S. federal rate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent Term of contract Lessee, Operating Lease, Term of Contract Issuance of common stock under Employee Stock Purchase Plan (in shares) Stock Issued During Period, Shares, Employee Stock Purchase Plans Counterparty Name [Axis] Counterparty Name [Axis] Schedule of Related Party Transactions Schedule of Related Party Transactions [Table Text Block] Founders Founder [Member] Represents information pertaining to founder member. Beginning balance (in shares) Ending balance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Less: Debt discount Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net Cash and Cash Equivalents [Axis] Cash and Cash Equivalents [Axis] Stock-based compensation Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Percent Number of shares authorized, increase (in shares) Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Shares Available For Grant, Increase (Decrease) Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Shares Available For Grant, Increase (Decrease) Accrued Expenses Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block] Schedule of Stock by Class [Table] Schedule of Stock by Class [Table] Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code State income taxes - net of federal benefit Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Effect of exchange rate changes on cash Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations Property and equipment, net Property and equipment, net Property, Plant and Equipment, Net Cash paid for amounts included in the measurement of lease liabilities: Operating Lease, Payments Repayments of principal on outstanding debt Repayments of Long-Term Debt Office equipment Office Equipment [Member] Change in fair value Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings Outstanding common stock options Share-Based Payment Arrangement, Option [Member] Expected volatility Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate Aggregate intrinsic value Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value [Abstract] n/a Debt Instrument, Redemption, Period [Domain] Debt Instrument, Redemption, Period [Domain] Issuance of common stock upon exercise of options Stock Issued During Period, Value, Stock Options Exercised Forfeited in period (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period Total minimum principal payments Long-Term Debt Adjusted net income (loss) Net Income (Loss) Attributable to Parent, Diluted Other income, net Other Nonoperating Income (Expense) Share price (in dollars per share) Sale of Stock, Price Per Share Common Stock, Shares Authorized Common stock, shares authorized (in shares) Common Stock, Shares Authorized Schedule of Related Party Transactions, by Related Party [Table] Schedule of Related Party Transactions, by Related Party [Table] Statement of Comprehensive Income [Abstract] Statement of Comprehensive Income [Abstract] Class of Warrant or Right [Axis] Class of Warrant or Right [Axis] Total operating expenses Operating expenses Operating Expenses Maximum Maximum [Member] Accumulated other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax Aggregate purchase price Aggregate Purchase Price Aggregate Purchase Price Options, RSUs and ESPP shares Shares available for future stock incentive awards Share-Based Payment Arrangement [Member] Long-term restricted cash Restricted Cash and Cash Equivalents, Noncurrent Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Deferred revenue Increase (Decrease) in Contract with Customer, Liability Total current assets Assets, Current Income taxes payable Taxes Payable, Current Less: Change in fair value of warrants Change in fair value of warrants Change in fair value of warrants Revenue recognized Contract with Customer, Liability, Revenue Recognized Research and Development Arrangement, Contract to Perform for Others, Type [Domain] Research and Development Arrangement, Contract to Perform for Others, Type [Domain] Entity Smaller Reporting Company Entity Small Business Debt instrument, default, bankruptcy, or insolvency value of triggering accelerated redemption Debt Instrument, Default, Bankruptcy, Or Insolvency Value Of Triggering Accelerated Redemption Debt Instrument, Default, Bankruptcy, Or Insolvency Value Of Triggering Accelerated Redemption Schedule of Stockholders' Equity Note, Warrants or Rights Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block] Measurement Frequency [Domain] Measurement Frequency [Domain] Equity Stockholders' Equity Note Disclosure [Text Block] Shares of common stock issued to employees under the ESPP (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period Issuances (in shares) Stock Issued During Period Shares Warranted Issued Stock Issued During Period Shares Warranted Issued Net income (loss) per share: Earnings Per Share, Basic and Diluted1 [Abstract] Earnings Per Share, Basic and Diluted1 Valuation technique, option pricing model Valuation Technique, Option Pricing Model [Member] Line of Credit Facility [Table] Line of Credit Facility [Table] Purchases of marketable securities Payments to Acquire Debt Securities, Available-for-Sale Summary of Significant Accounting Policies Significant Accounting Policies [Text Block] Number of Options Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward] Property and Equipment Property, Plant and Equipment Disclosure [Text Block] Base rent Operating Lease, Base Rent Operating Lease, Base Rent Non-cash interest expense Paid-in-Kind Interest Common Warrant Common Warrant [Member] Common Warrant [Member] Sublease Income Sublease Income Outstanding Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Long-Lived Tangible Asset [Domain] Long-Lived Tangible Asset [Domain] Accounts receivable Increase (Decrease) in Accounts Receivable Title of 12(b) Security Title of 12(b) Security Description of the Business Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Deferred revenue Effective Income Tax Rate Reconciliation, Deferred Revenue, Percent Effective Income Tax Rate Reconciliation, Deferred Revenue, Percent Fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, transfers, net Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net Payables and Accruals [Abstract] Payables and Accruals [Abstract] Subsequent Event [Line Items] Subsequent Event [Line Items] Repayments of lines of credit Repayments of Lines of Credit Debt Instrument [Line Items] Debt Instrument [Line Items] Class of Warrant or Right [Table] Class of Warrant or Right [Table] Class of Stock [Line Items] Class of Stock [Line Items] Fair Value Measurement Inputs and Valuation Techniques [Line Items] Fair Value Measurement Inputs and Valuation Techniques [Line Items] Lease liabilities Operating Lease, Liability U.S. government agency securities and treasuries US Government Agencies Debt Securities [Member] Expected volatility Measurement Input, Price Volatility [Member] Stock-Based Compensation Share-Based Payment Arrangement [Policy Text Block] Amortization of premiums and discounts on marketable securities Accretion (Amortization) of Discounts and Premiums, Investments Investments, Debt and Equity Securities [Abstract] Investments, Debt and Equity Securities [Abstract] Other financing fees Adjustments to Additional Paid in Capital, Other AskBio License AskBio License [Member] AskBio License [Member] Liabilities and stockholders’ equity Liabilities and Equity [Abstract] Milestone receivable License And Option Agreement, Milestone Receivable License And Option Agreement, Milestone Receivable Granted (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Fair Value, Recurring and Nonrecurring [Table] Fair Value, Recurring and Nonrecurring [Table] Amortized cost Debt Securities, Available-for-Sale, Amortized Cost 2017 PIPE 2017 PIPE [Member] 2017 PIPE [Member] Weighted average common shares outstanding: Denominator: Weighted Average Number of Shares Outstanding, Diluted [Abstract] Sale common stock Sale of Stock, Consideration Received on Transaction Sale of Stock, Consideration Received on Transaction Accounts payable Accounts Payable, Current Income Tax Authority [Axis] Income Tax Authority [Axis] Debt Instrument, Unamortized Discount Debt Instrument, Unamortized Discount Vested and expected to vest Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value Debt instrument, additional accrued interest in the event of default Debt Instrument, Additional Accrued Interest In the Event Of Default Debt Instrument, Additional Accrued Interest In the Event Of Default Auditor Location Auditor Location Warrants to purchase common stock Warrant liabilities Exercise of warrants Warrant [Member] Entity Filer Category Entity Filer Category Net proceeds from issuance of common stock Shares issued, value Proceeds from Issuance of Common Stock Basic (in shares) Weighted-average common shares outstanding, basic (in shares) Weighted Average Number of Shares Outstanding, Basic Liabilities: Liabilities, Fair Value Disclosure [Abstract] Total stock-based compensation expense Stock-based compensation expense Share-Based Payment Arrangement, Expense Cyrus Biotechnology, Inc. Cyrus Biotechnology, Inc. [Member] Cyrus Biotechnology, Inc. Noncash investing and financing activities Noncash Investing and Financing Items [Abstract] Commitments and contingencies Commitments and Contingencies Lease Arrangement [Domain] Lease Arrangement [Domain] [Domain] for Lease Arrangement [Axis] Security Exchange Name Security Exchange Name Beginning balance (in dollars per share) Ending balance (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Class of Warrant or Right [Domain] Class of Warrant or Right [Domain] At-The-Market Offering At-The-Market Offering [Member] At-The-Market Offering [Member] Fair value of warrants issued in connection with issuance of long-term debt Stock Issued Preferred stock, $0.0001 par value; 10,000,000 shares authorized; no shares issued and outstanding as of December 31, 2022 and December 31, 2021 Preferred Stock, Value, Issued Letters of credit outstanding, amount Letters of Credit Outstanding, Amount 2020 Term Loans 2020 Term Loans [Member] 2020 Term Loans Property, Plant and Equipment [Line Items] Property, Plant and Equipment [Line Items] Schedule of Term Loan And Unamortized Debt Discount Balances Schedule of Debt [Table Text Block] General and administrative General and Administrative Expense [Member] Warrant issued Warrant Issued Warrant Issued Collaboration and license revenue Revenue from Contract with Customer, Excluding Assessed Tax Class of warrant or right, expiration period Class Of Warrant Or Right, Expiration Period Class Of Warrant Or Right, Expiration Period Corporate bonds Corporate Bond Securities [Member] Entity Well-known Seasoned Issuer Entity Well-known Seasoned Issuer Schedule of Operating Leased Assets [Table] Schedule of Operating Leased Assets [Table] Income taxes payable Increase (Decrease) in Income Taxes Payable Total (in shares) Common stock authorized and reserved for future issuance (in shares) Common Stock, Capital Shares Reserved for Future Issuance Cover [Abstract] Cover [Abstract] Schedule of Long-term Debt Instruments [Table] Schedule of Long-Term Debt Instruments [Table] Leases Lessee, Leases [Policy Text Block] License and option agreement, payments made relative to calculated premium paid for initial equity investment made under the purchase agreement License And Option Agreement, Calculated Premium Paid For Equity Investment Under Purchase Agreement License And Option Agreement, Calculated Premium Paid For Equity Investment Under Purchase Agreement Level 3 Fair Value, Inputs, Level 3 [Member] Entity Voluntary Filers Entity Voluntary Filers Research tax credits Effective Income Tax Rate Reconciliation, Tax Credit, Percent Stock Incentive Plans Share-Based Payment Arrangement [Text Block] Schedule of Stock-Based Compensation Share-Based Payment Arrangement, Cost by Plan [Table Text Block] Other assets Other Assets Revenue Arrangements Revenue from Contract with Customer [Text Block] Deferred revenue Deferred Tax Assets, Deferred Income Debt Instrument, Redemption, Period Two Debt Instrument, Redemption, Period Two [Member] 3SBio License License Agreement With Shenyang Sunshine Pharmaceutical Company Limited [Member] Represents information pertaining to License agreement with Shenyang Sunshine Pharmaceutical co., ltd. Risk-free interest rate Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Documents Incorporated by Reference Documents Incorporated by Reference [Text Block] Total liabilities and stockholders’ equity Liabilities and Equity Number of shares authorized to be sold (in shares) Stock Purchase Program, Number Of Shares Authorized To Be Sold Stock Purchase Program, Number Of Shares Authorized To Be Sold Schedule of Deferred Tax Assets and Liabilities Schedule of Deferred Tax Assets and Liabilities [Table Text Block] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] 2022 Warrants 2022 Warrants [Member] 2022 Warrants Related Party [Axis] Related Party [Axis] Term B Loans Term B Loans [Member] Term B Loans Cash maintained in Russian bank accounts Cash Dilutive effect of employee equity incentive plans and outstanding warrants (in shares) Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements Patent costs Deferred Tax Assets, Goodwill and Intangible Assets Sales milestone payments License And Option Agreement, Sales Milestone Payments That May Be Received License And Option Agreement, Sales Milestone Payments That May Be Received Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Gross deferred tax assets Deferred Tax Assets, Gross Issuances Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Level 2 Fair Value, Inputs, Level 2 [Member] Canceled (in dollars per share) Stock Issued During, Warranted Canceled, Price Per Share Stock Issued During, Warranted Canceled, Price Per Share Debt Issuance Costs Debt, Policy [Policy Text Block] Debt Instrument, Redemption, Period One Debt Instrument, Redemption, Period One [Member] Current Fiscal Year End Date Current Fiscal Year End Date Option term License And Option Agreement, Option Term License And Option Agreement, Option Term Sale of stock, percentage of ten-day volume weighted average price of common stock Sale of Stock, Percentage Of Ten-Day Volume Weighted Average Price Of Common Stock Sale of Stock, Percentage Of Ten-Day Volume Weighted Average Price Of Common Stock Less imputed interest Lessee, Operating Lease, Liability, Undiscounted Excess Amount Diluted (in dollars per share) Earnings Per Share, Diluted Sale of Stock [Domain] Sale of Stock [Domain] Proceeds from the sale of property and equipment Proceeds from Sale of Property, Plant, and Equipment Award vesting term Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period Issuance costs Payments of Stock Issuance Costs (Gain) on disposal of property and equipment Gain (Loss) on Disposition of Property Plant Equipment Schedule of Authorized Shares of Common Stock for Future Issuance Schedule of Stock by Class [Table Text Block] Stock-based compensation expense APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Change in fair value of warrant liabilities Warrant liabilities revaluation Fair Value Adjustment of Warrants Total current liabilities Liabilities, Current Vested (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Number of Shares 2024 Lessee, Operating Lease, Liability, to be Paid, Year Two Unrecognized tax benefits Unrecognized Tax Benefits Reclassification of warrant liability to equity Noncash Or Part Noncash, Reclassification Of Warrant Liability To Equity Noncash Or Part Noncash, Reclassification Of Warrant Liability To Equity Receivables Billing Status [Domain] Receivables Billing Status [Domain] Russian subsidiary Russian subsidiary RUSSIAN FEDERATION Remaining performance obligation Revenue, Remaining Performance Obligation, Amount Non-current liabilities: Other Liabilities, Noncurrent [Abstract] Net proceeds from issuance of common stock Proceed From Issuance Of Common Stock, Net Proceed From Issuance Of Common Stock, Net Schedule of Lessee, Operating Lease, Liability, Maturity Lessee, Operating Lease, Liability, Maturity [Table Text Block] Entity Address, Address Line One Entity Address, Address Line One Income Tax Authority [Domain] Income Tax Authority [Domain] Other financing fees Proceeds from (Payments for) Other Financing Activities Deferred revenue related to agreement Contract liabilities, beginning of period Contract liabilities, end of period Contract with Customer, Liability 2008 Plan, 2016 Plan, and 2018 Inducement Incentive Award Plan 2008 Plan, 2016 Plan, and 2018 Inducement Incentive Award Plan [Member] 2008 Plan, 2016 Plan, and 2018 Inducement Incentive Award Plan Research and development Research And Development [Member] Represents the information pertaining to research and development expenses included in the income statement. Class of Stock [Domain] Class of Stock [Domain] Valuation allowance, deferred tax asset, increase (decrease), amount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount Contingent Liabilities Contingent Liability Reserve Estimate, Policy [Policy Text Block] Fair Value Disclosures [Abstract] Fair Value Disclosures [Abstract] Collaboration and License Agreements upfront payment Collaboration and License Agreements upfront payment Collaboration and License Agreements upfront payment Subsidiary, Sale of Stock [Line Items] Subsidiary, Sale of Stock [Line Items] Interest expense Interest Expense Warrant, decrease in equity, amount Warrant, Down Round Feature, Increase (Decrease) in Equity, Amount Credit Facility [Axis] Credit Facility [Axis] Unrealized (losses) on marketable securities Unrealized loss on marketable securities OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax Accrued patent fees Accrued Patent Fees Current Carrying value as of the balance sheet date of patent fees. Schedule of Accrued Expenses Schedule of Accrued Liabilities [Table Text Block] Cash and Cash Equivalents [Domain] Cash and Cash Equivalents [Domain] Astellas Astellas [Member] Astellas Equity [Abstract] Equity [Abstract] Subsequent Event [Table] Subsequent Event [Table] Vested in period (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Unvested restricted stock units Restricted Stock Units, Unvested [Member] Restricted Stock Units, Unvested Net proceeds from issuance of common stock and common warrants Proceeds from Issuance of Warrants Entity Tax Identification Number Entity Tax Identification Number Exercises Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Exercises In Period Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Exercises In Period Gross deferred tax liabilities Deferred Tax Liabilities, Gross Revenue from Contract with Customer [Abstract] Revenue from Contract with Customer [Abstract] Unbilled receivables Contract assets Contract with Customer, Asset, after Allowance for Credit Loss, Current Issuance of common stock through at-the-market offering, net (in shares) Stock Issued During Period, Shares, Other Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Schedule of Effective Income Tax Rate Reconciliation Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] Net change in cash, cash equivalents, and restricted cash Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Exercises (in shares) Stock Issued During Period Shares Warrants Exercised Number of warrants exercised during the current period. Commercial paper Commercial Paper [Member] Entity Central Index Key Entity Central Index Key Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Measurement Frequency [Axis] Measurement Frequency [Axis] Research and Development Costs Research and Development Expense, Policy [Policy Text Block] Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Collaborative Arrangement, Payment Obligation Collaborative Arrangement, Payment Obligation Collaborative Arrangement, Payment Obligation Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Canceled (in shares) Stock Issued During Period Shares Warrants Canceled Stock Issued During Period Shares Warrants Canceled Concentrations of Credit Risk and Off-Balance Sheet Risk Concentration Risk, Credit Risk, Policy [Policy Text Block] Other Other Accrued Liabilities, Current Issuance of common stock upon exercise of pre-funded warrants (in shares) Stock Issued During Period, Shares, Pre-Funded Warrants Exercised Stock Issued During Period, Shares, Pre-Funded Warrants Exercised Measurement Input Type [Axis] Measurement Input Type [Axis] City Area Code City Area Code General and administrative General and Administrative Expense Assets Assets [Abstract] Retirement Benefits [Abstract] Retirement Benefits [Abstract] Collaboration and License Agreements Collaboration And License Agreements [Text Block] Collaboration And License Agreements Exercises (in dollars per share) Warrant, Exercise Price, Increase Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Sale of Stock [Axis] Sale of Stock [Axis] Proceeds from maturities of marketable securities Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-Sale Debt Instrument, Redemption, Period [Axis] Debt Instrument, Redemption, Period [Axis] Net Income (Loss) Per Share Earnings Per Share, Policy [Policy Text Block] Clinical and commercial milestone payment, expected License And Option Agreement, Clinical And Commercial Milestone Payment, Expected License And Option Agreement, Clinical And Commercial Milestone Payment, Expected 2023 Long-Term Debt, Maturity, Year One Stock-based compensation expense Share-Based Payment Arrangement, Noncash Expense Upfront cash payment License And Option Agreement, Upfront Cash Payment License And Option Agreement, Upfront Cash Payment Weighted average grant date fair value of stock options (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Issuance of common stock through at-the-market offering, net Stock Issued During Period, Value, Other Revenue recognized from performance obligations Contract with Customer, Liability, Cumulative Catch-up Adjustment to Revenue, Change in Estimate of Transaction Price Class of warrant or right, outstanding (in shares) Class of warrant or right, outstanding, beginning balance (in shares) Class of warrant or right, outstanding, ending balance (in shares) Class of Warrant or Right, Outstanding Loan payable, net of current portion Loans Payable, Noncurrent Purchases of property and equipment Payments to Acquire Property, Plant, and Equipment Disaggregation of Revenue [Line Items] Disaggregation of Revenue [Line Items] Computation of Basic and Diluted Net Loss Per Share Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Milestone payment License And Option Agreement, Milestone Payments License And Option Agreement, Milestone Payments Deductions Contract with Customer, Liability, Deferred Revenue, Revenue Recognized Contract with Customer, Liability, Deferred Revenue, Revenue Recognized